← All Sponsors
SPONSOR

BeOne Medicines

Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2, Phase 1
Conditions studied: B-cell MalignancyMarginal Zone LymphomaFollicular LymphomaNon-Hodgkin LymphomaWaldenström MacroglobulinemiaChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell LymphomaDiffuse Large B Cell LymphomaSkin Diseases
NCT05006716 Phase 1, Phase 2
Recruiting

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

B-cell Malignancy
United States, Australia, Brazil View Trial →
NCT07412691 Phase 1
Recruiting

A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases

Skin Diseases
China View Trial →
NCT06233942 Phase 1
Recruiting

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

Advanced Solid Tumor
United States, Australia, Brazil View Trial →